Harbour BioMed has entered a strategic partnership with Otsuka focusing on the development of HBM7020 for treating autoimmune ...

The EC has approved argenx’s Vyvgart (efgartigimod alfa) 1000mg as a single agent for subcutaneous injection to treat CIDP.

An EMA committee has recommended approval of Alvotech’s AVT06, a biosimilar to Bayer’s blockbuster ophthalmology drug Eylea.

Dedicated datasets highlight how social determinants of health can be used to improve overall standards of care.

Discover why leaders in the pharmaceutical industry are investing in future-ready, smart digital strategies for process ...

Shares in both companies were down following news of the second death, casting fresh safety concerns over Elevidys.

Lisata Therapeutics has formed a strategic partnership with GATC Health for advancing AI-driven drug discovery and ...

Nicole Verdun, a highly respected individual in the cell and gene therapy space, was placed on administrative leave this week ...

NextCure has entered a strategic partnership with Simcere Zaiming, to develop SIM0505, a new ADC targeting CDH6 for treating ...

The FDA launched a new Priority Review program, as uncertainty persists for the existing programme for paediatric disorders.

Health Canada has granted a notice of compliance for Novartis Canada’s Kisqali (ribociclib tablets) plus an aromatase ...